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Abstract In 1886 Pierre Marie used the term ‘‘acro-
megaly’’ for the ﬁrst time and gave a full description of the
characteristic clinical picture. However several others had
already given clear clinical descriptions before him and
sometimes had given the disease other names. After 1886,
it gradually became clear that pituitary enlargement
(caused by a pituitary adenoma) was the cause and not the
consequence of acromegaly, as initially thought. Pituitary
adenomas could be found in the great majority of cases. It
also became clear that acromegaly and gigantism were the
same disease but occurring at different stages of life and
not different diseases as initially thought. At the end of the
19th and beginning of the 20th century most information
was derived from case descriptions and post-mortem
examinations of patients with acromegaly or (famous)
patients with gigantism. The stage was set for further
research into the pathogenesis, diagnosis and therapy of
acromegaly and gigantism.
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In 1886 Pierre Marie (1853 Paris (France)—1940 Paris
(France)) used the term ‘‘acromegaly’’ for the ﬁrst time and
gave a full description of the characteristic clinical picture:
‘‘Il existe une affection caracte ´rise ´e surtout par une hy-
pertrophie des pieds, des mains et du visage, que nous
proposons d’appeler acrome ´galie, c’est-a `-dire hypertrophie
des extre ´mite ´s (non pas qu’en re ´alite ´, les extre ´mite ´s soient
seules atteintes pendant toute la dure ´e de la maladie, mais
parce que leur augmention de volume est un phe ´nome `ne
initial et constitue le trait le plus caracte ´ristique de cette
affection). L’acrome ´galie est tout a fait distincte du myx-
œde `me et de la maladie de Paget (oste ´ite de ´formante), ainsi
que de la leontiasis ossea de Virchow’’ [1] [A condition
characterized by hypertrophy of the hands, feet and the
face exists which we propose to be called «acromegaly»
which means hypertrophy of the extremities. In reality the
extremities are swollen during the disease course and their
increase in volume is the most characteristic feature of this
disease. Acromegaly is different from myxedema, Paget’s
disease or leontiasis ossea of Virchow.] Marie, however,
was not the ﬁrst physician to give a clear description of the
clinical picture of acromegaly. Others had done this years
before him, like (possibly) the Dutch surgeon and active
opponent of superstition and witch-burning, Johannes Wier
(1515–1588) already in 1567 [2], or Saucerotte in 1772 [3,
4]. Other physicians had also given the disease different
names including Alibert in 1822 calling it ‘‘Ge ´ant scrofu-
leux’’ [5], Verga in 1864 calling it ‘‘Prosopo-ectasia’’ [6]
and Lombroso in 1869 calling it ‘‘Macrosomia’’ [7, 8]. A
total of more than 20 physicians had already published on
disorders, which later could be reclassiﬁed as cases of
acromegaly (Table 1). In 1886, Marie was not yet aware of
any pituitary pathology in patients with acromegaly. In the
following years he and his co-workers J. D. Souza-Leite
and G. Marinesco signiﬁcantly contributed to further
knowledge on the clinical features and pathology of acro-
megaly by publishing many important papers in this ﬁeld
[9–19]. Several authors had reported on the coexistence of
sellar, or pituitary enlargement in patients with acromeg-
aly, but it was not clear whether this was the cause or the
consequence of the disease. It was also debated whether
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pituitary. In 1864 Verga had already described sellar
enlargement in a patient with acromegaly. Minkowski in
1887 reported that pituitary enlargement was found in all
postmortem studies of patients with acromegaly [20].
Massolongo in 1892 could correlate acromegaly to
increased pituitary function by demonstrating that a pitui-
tary tumor from a patient with acromegaly contained
speciﬁc granulated cells [21]. Eventually, the relationship
between a pituitary hyperfunction-hypertrophy, or a
hyperfunctioning pituitary tumor and acromegaly was
clearly established and conﬁrmed at the end of the 19th
century by many authors [22–27]. Initially, it was also
believed that acromegaly and gigantism were two totally
different diseases. Marie [11–17], his intern Souza-Leite
[9] and Guinon [28] were convinced that acromegaly and
gigantism were two entirely different disorders. Gigantism
was considered as an exaggerated variant of normal
development, whereas acromegaly was considered as a
pathological condition. However, Fritsche and Klebs in
1884 [29], supported by the work of Langer (1872) [30],
concluded that in contrast to gigantism, which they con-
sidered as a congenital disorder, acromegaly was an
acquired variety of gigantism occurring at a later age when
growth is completed. In 1894 Sternberg concluded that
there were many similarities between acromegaly and
gigantism [31]. However, in 1897 he changed his view and
agreed with Marie and others that both disorders were
different [32]. Cunningham in 1891—studying the skeleton
of the Irish giant Cornelius Magrath (1736 Silvermines
(Ireland)—1760, Dublin (Ireland); the skeleton was the
possession of Trinity college, Dublin) [33–35], Dana in
1893 [36] and Hutchinson in 1893 [37–40]—describing the
case report and postmortem studies of the French giantess
Emma Aline Batallaid (also known as Lady Aama, 1877–
1895)—also pointed to the connection between acromegaly
and gigantism. It gradually became clear that both disor-
ders had the same pathogenetic mechanism, but differed
with regard to the age of onset. Gigantism would occur
much earlier in life, when the skeleton still had the potency
to grow, a developmental phase we now call pre-pubertal
[41, 42].
The famous surgeon John Hunter could have been the
ﬁrst to describe pituitary enlargement in gigantism/acro-
megaly, if only he would have opened the skull of the giant
Charles Byrne of Littlebridge (Ireland) (later also known as
O’Brien) whose remains came into Hunter’s possession
after the death of the giant in London (UK) in June 1783.
But, as stated by the famous neurosurgeon Harvey Cush-
ing, ‘‘his passion as a collector exceeded his thirst for
knowledge’’ [43]. In 1909, Cushing together with the
curator of the John Hunter museum in London (UK)
opened the skull of the Irish giant and demonstrated that
the sella turcica was enlarged measuring 21 9 24 mm and
being 11 mm deep [43–46].
So, ﬁnally in the early years of the 20th century the
cause of acromegaly and gigantism had become known.
An abnormal stature, or phenotype, like being too tall
attracted the attention of the community and also doctors.
Therefore, many case reports on generally famous giant
acromegalic patients have been subsequently published by
experts in the ﬁeld.
Besides from being an expert pathologist, Professor
Rudolf Ludwig Karl Virchow (1821, Schievelbein (Prus-
sia)—1902, Berlin (Germany)) also showed particular
interests in anthropology. He wrote two papers on famous
patients with gigantism; Lewis Wilkins and Franz Wink-
elmeier [47–49].
Lewis Wilkins (1874, Minnesota (USA)—1902,
Chicago, (USA)) (Fig. 1) had a reported height which
varied between 2.26 m. (7 ft. 5 in.) and 2.535 m. (8 ft.
3 in.). An impressive feature was his asymmetrical left
facial hypertrophy, which was initially diagnosed as
‘‘leontiasis ossea’’ [36, 48, 50]. Months before his death he
ﬁrst suddenly lost the vision in his left eye and suffered
from excruciating headaches. Later he became blind in his
right eye. He also experienced deafness in the left ear and
Table 1 Description of acromegaly in the medical literature up to
1886
Author Reference Number Year of Publication
Weyer [2] 1567
Saucerotte [3] 1772
Noel [42] 1779
Gall [91] 1810
Alibert [5] 1822
Verga [6] 1864
Lombroso [7] 1869
Magendie [92] 1839
Chalk [93] 1857
Friedreich [94] 1868
Henrot
a [95, 96] 1877
Brigidi
b [97, 98] 1877
Tarufﬁ [99, 100] 1877
Cunningham [101] 1879
Ellinwood [102] 1883
Fritsche and Klebs [29] 1884
Hadden and Balance [103, 104] 1885
Wadsworth [105] 1885
Wilks [42] 1886
Motais [42] 1886
a Describes the postmortem ﬁnding of a tumor at the base of the brain
in the midline–pituitary area
b Life history and postmortem report of the famous Italian actor
Ghirlenzoni
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123loss of feeling on the left side of the face and the left part of
his tongue. He died from ulcerative colitis accompanied by
bronchopneumonia. He was autopsied by Drs. P. Bassoe, L.
Loeb, and Prof. Hektoen at the Presbyterian Hospital in
Chicago (USA). A sarcomatous tumor with extension in
the pituitary area and diffuse left sided hyperostosis was
found. The pituitary seemed normal. The thyroid was
multinodular and enlarged [51, 52].
Franz Winkelmeier (1860, Lengau (Austria)—1887,
Lengau (Austria)) started growing rapidly at puberty and
attained a ﬁnal height of 2.278 m (7 ft 6 in). He died of
tuberculosis [47, 53].
Fedor Machnow (1880, Kustiaki/Witebsk (Russia)—
1920, USA)) (Fig. 2) started to grow rapidly from the age
of 4 years. Drs. Von Luschan and Lissauer (Berlin, Ger-
many) reported his anthropometrics in 1903 when he was
22 years old [54]. His height was 2.38 m (7 ft 9 in), his
feet were 149 mm (5 in) wide and 370 mm (1 ft 2 in)
long. He was described as being of normal intelligence. In
1904, at the age of 23, Dr. M. Zondek was able to repeat
the anthropometry [55]. In this paper a height of 2.36 m
(7 ft 9 in) is reported. A skull radiograph was also made,
but a description of the sella turcica is, regretfully, lacking.
However, the skull radiograph did show extensive
pneumatisation of the frontal sinuses. Interestingly, the
publication describes a remarkable increase in pulse fre-
quency from the supine position (68 beats per minute—
b.p.m.) to the erect position (108 b.p.m.) suggestive of
orthostasis. A radiograph of the hand showed complete
ossiﬁcation, suggesting that Machnow had stopped grow-
ing. He died of tuberculosis.
A post-mortem examination of Battista Ugo (in French:
Baptiste Hugo; 1876, Vinadio (Italy)—1916, New York
(USA)) was performed and published by Symmers in 1917
[56]. He was one of the Hugo brothers, also known in
France as ‘‘les Geants des Alpes’’ (Fig. 3). Baptiste
attained a height of 2.30 m. (7 ft. 7 in.) and weighed
201 kg. (443 lbs.). His brother Paolo Antonio Ugo (in
French: Antoine Hugo; 1887, Vinadio (Italy)–1914, Mair-
sons-Alfort (France)) had a ﬁnal height of 2.25 m. (7 ft.
5 in.) and he weighed 150 kg. (331 lbs.). They had 3
brothers and 2 sisters of normal length [57]. Baptiste Hugo,
while traveling the USA working for the Barnum & Bailey
circus was admitted to the William Parker hospital in New
Fig. 1 Lewis Wilkins (1874, Minnesota (USA)—1902, Chicago,
(USA)) together with Professor Rudolf Ludwig Karl Virchow (1821,
Schievelbein (Preussen)—1902, Berlin (Germany) and his team in
1900 in Berlin (Germany). Collection W.W. de Herder
Fig. 2 Fedor Machnow (1880, Kustiaki/Witebsk (Russia)—1920,
(USA)) photographed at the ‘‘London Hippodrome, London (UK) in
1905. Collection W.W. de Herder
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123York on 22 April 1916 with the diagnosis of diphtheria and
died the next day (23 April 1916). In the post-mortem
report his height is reported as 2.59 m. (8 ft. 10 in.), which
is much taller than his reported height when still alive. The
report further describes testicular atrophy, micropenis and
scanty pubic, facial and axillary hair as features of hypo-
gonadism. Osteoporosis of the skull bones was found.
Clear acromegalic features were described including:
frontal bossing, prognathism and the large size of both
hands as well as most internal organs. A pituitary adenoma
measuring 50 9 25 9 23 mm. (2 9 1 9 0.9 in.) and
weighing 5.94 gram with suprasellar expansion compress-
ing both optic nerves, and also left parasellar and
retrosellar expansion was found. Further ﬁndings were: a
so-called ‘‘cystic adenoma’’ of the thyroid and atrophy of
both adrenals [56]. The Hugo brothers are presumably the
ﬁrst patients with familial acromegaly to be described in
the literature.
Frederic John Kempster (1889, Bayswater, London
(UK)—1918, Blackburn (UK))–was also known as ‘‘the
Blackburn Giant’’ or ‘‘The Gentle Essex Giant’’ or ‘‘Fred-
erick the Great’’ (Fig. 4)[ 58]. At the onset of the age of 15,
he experienced rather severe headaches and started growing
rapidly. At his death at the age of 29 he was 2.56 m. (8 ft.
4 in.) and weighed 171.5 kg. (378 lbs.) and wore size 22
shoes (410 mm., 16 inches long). Anthropometrics and his
casehistoryweretakenbyDr.Gigon(Basle,Switzerland)in
1915 [59,60]. He was ofnormalintelligence. He had typical
acromegalic features including: prognathism, large hands, a
big nose and a large tongue. The right foot was 34 cm (1 ft.
1 in.) and the left foot size was 32,5 cm (1 ft. 1 in.) in
length. He had a kyphoscoliosis. He had a deep voice
although heusedtobeatenoruntiltheageof18.Therewere
signs of hypogonadism as: the absence of a beard and a
moustache as well as the absence of axillary hair or chest
hair. There was scanty pubic hair. Testis size was normal for
Fig. 3 Familial acromegaly. Battista Ugo (Baptiste Hugo; 1876,
Vinadio (Italy)—1916, New York (USA))—the tallest person in the
picture), Paolo Antonio Ugo (Antoine Hugo; 1887, Vinadio (Italy)—
1914, Mairsons-Alfort (France)) and their father (the smallest person
in the picture). Collection W.W. de Herder
Fig. 4 Frederic John Kempster (1889, Bayswater, London (UK)—
1918, Blackburn (UK)). Collection W.W. de Herder
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123a normal-sized man. The left leg was shorter than the right
leg. The muscles were weak. A sellar radiograph showed an
enlarged sella turcica with a diameter of 28 mm (1 in). A
hand radiograph showed that the epiphysial plates had not
yetfullyclosed.Furthermoretherewasmarked osteoporosis
[59, 60]. In 1910 he traveled to Germany, to work in the
vaudeville where he was called ‘‘Teddy Bobs’’. At the out-
break of the First World War he was interned as a ‘‘prisoner
of war’’ by the Germans in 1914. He prompt fell ill and was
hospitalized until his release in 1916. Back in England, his
health remained poor and in 1918 he fell ill with pneumonia
as a result of the inﬂuenza epidemic and died [58].
The Swiss anthropologist Schlaginhaufen examined the
Dutch giant Albert Johan Kramer (1897, Amsterdam, The
Netherlands), also known as ‘‘Lofty’’ (UK) and ‘‘Jan van
Albert’’ (USA and Europe) in July 1923 in Albisgu ¨tli
(Switzerland) (Fig. 5)[ 61]. Kramer’s ﬁnal height was
2.42 m. (8 ft.), although his maximum reported height
was 2.69 m. (8 ft. 9 in.) [61, 62]. He weighed 165 kg
(364 lbs). Schlaginhaufen was able to register 40 anthro-
pometric data except his overall height, because of
‘‘Gescha ¨ftsgeheimnis’’ (professional secrecy), reported by
Kramer himself as 2.54 m.(8 ft. 4 in.). He also was con-
vinced that Kramer did not suffer from acromegaly [61, 62].
Dr. Charles D. Humberd of Barnard, Mo. wrote 2
reports on 2 famous patients with gigantism. Henri Mullins
(1915, Atlanta (Georgia, USA)—1972, Los Angeles
(USA)) was described by Humberd as an acrobatic, alert,
intelligent, well-read, affable, friendly, thoroughly quali-
ﬁed businessman and a ‘‘good trouper’’. He underwent one
single course of pituitary radiotherapy. He did not suffer
from visual impairment. He had a normal libido and nor-
mal testes. There were no headaches. There were multiple
(scars of) furuncles and slight acne. A complete anthro-
pometric picture was given by Humberd in his publication
in 1938: His height then was 2.305 m. (7 ft. 6 in.), the
circumference of his ring ﬁnger (dig IV) was 8 cm.
(3 in.), the length of the feet was 39 cm. (1 ft. 3 in)
[63]. He worked as a vaudeville and movie artist. His
theatre name was ‘‘Henri Hite’’. Among the movies he
acted in were: ‘‘The Side Show Mystery’’ (1932) and
‘‘Monster a-Go Go’’ (1965).
Robert Pershing Wadlow, (1918, Alton, Illinois
(USA)—1940, Manistee, Michigan (USA)) is still consid-
ered as the tallest man on earth from the year 1937 onwards
(Fig. 6). His ﬁnal height was 2.72 m (80 11.100)[ 64]. His
Fig. 5 Albert Johan Kramer (1897, Amsterdam, The Netherlands).
Collection W.W. de Herder
Fig. 6 Robert Pershing Wadlow, (1918, Alton, Illinois (USA)—
1940, Manistee, Michigan (USA)) and his father. Collection W.W. de
Herder
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123case was already reported by Behrens in 1932 [65]. At the
time of his death he weighed 222 kg (490 pounds). In June
1936 Wadlow was visited at his home by Humberd. The
story goes that Humberd more or less imposed himself on
the Wadlow family and after a short visit left disgruntled
the house when Wadlow refused to cooperate and refused
a medical examination [66]. Successively, Humberd
published a paper in the JAMA describing Wadlow as a
‘‘pre-acromegalic giant’’ [67]. The Wadlow family was
especially mortiﬁed and grieved by the following phrase in
the Humberd paper: ‘‘His expression is surly and indif-
ferent, and he is deﬁnitely inattentive, apathetic and
disinterested, unfriendly and antagonistic. His frequently
voiced plaints are: ‘‘It’s not my fault that I am this way’’,
and ‘‘I didn’t have anything to do with me getting to be like
this’’. His soured attitude has embittered him very much,
and he is introverted and morose, though the newspaper
stories, usually quoting his school teachers, say that he is
very alert and intelligent. His defective attention and slow
responses hold for all sensory stimuli, both familiar and
unexpected, but he does manifest a vapid interest in seeing
any memoranda made by a questioner’’. Humberd further
doubted Wadlow’s intellectual capacities [67]. The publi-
cation was considered by the Wadlow family as insulting
and humiliating. They felt violated as, they put is, they had
not realized that ‘‘any person in the name of science had
the right to come into a home, make whatever cursory
observations he could and then broadcast these observa-
tions to the world’’ [66]. The Wadlows ﬁled suit against
Humberd and the American Medical Association. Despite
the fact that many witnesses veriﬁed that the description of
Wadlow, as published, was a distortion of his general
condition, they lost the trial on a technicality. The judge
ruled that the description was a case study and that the
portrait of Robert might have been accurate on the day of
his examination [66]. The action against the American
Medical Association never came to trial. After three years
of maneuvers it was dismissed after Robert died 15 July
1940 in Manistee, Michigan as a result of an infected ulcer
caused by pressure of a brace which he had to wear because
of peroneal nerve paralysis (drop foot). He was buried in
his hometown Alton, Illinois (USA).
A case report of John Aasen, (1890, Hennepin County
(Minnesota, USA)—1938, Mendocino (California, USA))
at the age of 46 years was published in 1937 by Gray [68].
His growth and weight history are also given. At age 46 his
length was 2.13–2.33 m. (7 ft. 0–9 in.) and his weight was
129.3 kg (285 lbs). The report describes a number of
examinations and tests which were done during a hospital
admission because of foot ulcers. The medical history
revealed that he had frontal headaches since the age of 28.
There was progressive loss of the bitemporal visual ﬁelds
from the age of 31 till age of 41 after which there was
stabilization but no improvement. His IQ was low and his
memory was poor. Libido was absent. He is described as
‘‘obviously acromegalic’’ and ‘‘a veritable giant’’. The
report further mentions scanty body hair and epilepsy since
the age of 41. Ophthalmologic examination revealed
bitemporal hemianopsia and optic atrophy. The testes were
small and soft with a length of about 2 cm. Glucose
intolerance and secondary hypothyroidism (low basal
metabolic rate) were diagnosed. A skull X-ray showed
hyperostosis. The sella turcica was enlarged with a diam-
eter of 2 cm but there was no erosion of the bone. The
treatment consisted of a hypercaloric diet, iron, liver and
stomach concentrate, adrenal cortex extract and thyroid
extract. It was decided to postpone pituitary surgery ‘‘until
the general vigor could be improved’’. Also pituitary
radiotherapy was not given because of ‘‘the probability that
the patient would leave town (San Francisco) shortly so
that follow-up would be inadequate’’ [68]. He died one
year later. John Aasen became famous because of his part
in the Harold Lloyd movie classic ‘‘Why Worry?’’ (1923).
He acted in several other ﬁlms. He was also known as the
‘‘The Minneapolis Giant’’, or the ‘‘Norwegian Giant’’. He
had willed his body to Dr. Humberd for research purposes
and dissection. The actual location of his skeleton after the
death of Dr. Humberd is yet unknown.
Jacob Ehrlich (Jack Earle) (1906, Denver (Colorado,
USA)—1952 El Paso (Texas, USA)) developed normally
until the age of 8. From then on he grew rapidly until the
age of 16 (Fig. 7). His ﬁnal height was 2.32 m. (7 ft
7.5 in), although he claimed to be 2.59–2.62 m. (8 ft
6–7 in). He grew up in El Paso, Texas where he also ﬁn-
ished high school, and obtained his nicknames: ‘‘Pecos
Bill’’, ‘‘The Texas Giant’’, ‘‘The El Paso Giant’’, and
‘‘Texas Jack’’. He worked in the movie business, painted,
and sculpted. He was a prize-winning photographer and a
poet (he published a book of poetry called: ‘‘The Long
Shadows’’).
In 1932 he was examined by Rowe and Mortimer who
alsorecordedsomeanthropometricdata[69].Hisheightwas
228.6 cm(7 ft6 in)andheweighed163.3 kg(360 lbs).The
lengthofthehandswas254 mm(10 in)andthelengthofthe
feet was 330 mm (1 ft 1 in). Ophthalmology revealed nor-
mal visual acuity. The blood sugar level was claimed to be
slightly elevated: 6.4 mmol/l (117 mg/dl). On the skull
radiograph hyperostosis frontalis, together with excessive
pneumatisation of the maxillary and frontal sinuses was
found. Also, a profound prognathism was recorded. The
sellar diameters were: 11 9 14 mm and the sellar ﬂoor was
depressed, which was claimed to be suggestive of an intra-
sellar tumor. Jack Earle’s movie career came to an end after
a fall during the ﬁlming of one of his movies. He broke his
nose and needed hospitalization. During hospital admission,
he ﬁrst lost his temporal eyesight and within the next few
Pituitary (2009) 12:236–244 241
123days he developed complete blindness. This was presum-
ably caused by a pituitary macroadenoma compressing the
optic chiasm and nerves. He was treated with external
pituitary radiotherapy, which resulted in the restoration of
his visual acuity. It was also claimed that the pituitary
radiotherapy may have stopped his further growth. In 1942,
Franks reported on a successful esthetic operation to correct
severe overbite in Jack Earle [70]. Jack Earle died as a result
of a fatal car crash.
Johann Petursson (Jo ´hann Svarfdælingur—1913, Dalvik
(Iceland)—1984, Dalvı ´k (Iceland)) had a normal develop-
ment till the age of 15 after which accelerated growth
occurred (Fig. 8). At the age of 17 he was very strong and
could lift a lorry, but at the age of 20 he was weak and
suffered from walking difﬁculties. At the age of 22, he was
studied by Krabbe in Copenhagen in 1935, who also
recorded his anthropometric data [71]. His height was
2.205 m. (7 ft 2 in), his weight was 135 kg (298 lbs).
Krabbe at that stage initially doubted whether Petursson
was suffering from acromegalic gigantism, as his body
proportions were normal and there were no signs of
hypogonadism. However, a sellar radiograph revealed a
considerably enlarged sella turcica (3 cm, 1.2 in). He was
re-examined in 1939 by Gu ¨nther in Leipzig and again
measured [72–74]. At that time he had a height of 2.225 m
(7 ft 3 in). He was featured in ﬁlms and magazines, and
appeared with every major circus and carnival until he
retired. His artists names were ‘‘Olaf’’ and ‘‘der Nordische
Riese Olaf’’ in Germany and ‘‘the Icelandic Giant’’ or ‘‘the
Viking giant’’ in the US. He is buried in Dalvik (Iceland).
What happened in next decades is well-reviewed. Case
reports made place for studies into the epidemiology of
acromegaly and gigantism. The physiology of the growth
hormone—IGF system was slowly unraveled. The patho-
physiology of growth disorders was further studied. Assays
for growth hormone, its receptors, IGF-I and its binding
proteins were developed. MRI became the standard imag-
ing technique for sellar pathologies. Pituitary surgery
and pituitary radiotherapeutical techniques and protocols
were developed and are continuously being improved.
Therapeutic regimens for treating growth hormone excess
Fig. 7 Jacob Ehrlich (Jack Earle) (1906, Denver (Colorado, USA)—
1952 El Paso (Texas, USA)). Collection W.W. de Herder
Fig. 8 Johann Petursson (Jo ´hann Svarfdælingur) (1913, Dalvik
(Iceland)—1984, Dalvı ´k (Iceland)). Collection W.W. de Herder
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123and for replacement of pituitary insufﬁciencies were and
still are being developed, tested and applied in clinical
practice [44, 45, 75–89]. Early recognition of developing
gigantism at a young age and adequate medical care in the
western countries are the main reasons why gigantism has
almost completely disappeared in the western world. [90].
But in Africa, South America and Asia gigantism is cur-
rently still diagnosed at a late stage.
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